A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function
Open Access
- 3 May 2012
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 119 (18) , 4182-4191
- https://doi.org/10.1182/blood-2011-10-383281
Abstract
Atypical hemolytic uremic syndrome (aHUS) is a rare renal thrombotic microangiopathy commonly associated with rare genetic variants in complement sysKeywords
This publication has 43 references indexed in Scilit:
- Structures of C3b in Complex with Factors B and D Give Insight into Complement Convertase FormationScience, 2010
- Complement: a key system for immune surveillance and homeostasisNature Immunology, 2010
- Insights into complement convertase formation based on the structure of the factor B-cobra venom factor complexThe EMBO Journal, 2009
- Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitorNature Immunology, 2009
- Structure of complement fragment C3b–factor H and implications for host protection by complement regulatorsNature Immunology, 2009
- 3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertaseProceedings of the National Academy of Sciences, 2009
- Translational Mini-Review Series on Complement Factor H: Renal diseases associated with complement factor H: novel insights from humans and animalsClinical and Experimental Immunology, 2008
- Translational Mini-Review Series on Complement Factor H: Genetics and disease associations of human complement factor HClinical and Experimental Immunology, 2007
- Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndromeProceedings of the National Academy of Sciences, 2007
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004